أعرض في EDS

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

التفاصيل البيبلوغرافية
العنوان: Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
المؤلفون: Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Benoît Funalot, Pierre-Marie Gonnaud, Arnaud Lacour, Yann Péréon, Odile Dubourg, Jean Pouget, Joëlle Micallef, Jérôme Franques, Marie-Noëlle Lefebvre, Karima Ghorab, Mahmoud Al-Moussawi, Vincent Tiffreau, Marguerite Preudhomme, Armelle Magot, Laurène Leclair-Visonneau, Tanya Stojkovic, Laura Bossi, Philippe Lehert, Walter Gilbert, Viviane Bertrand, Jonas Mandel, Aude Milet, Rodolphe Hajj, Lamia Boudiaf, Catherine Scart-Grès, Serguei Nabirotchkin, Mickael Guedj, Ilya Chumakov, Daniel Cohen
المصدر: Orphanet Journal of Rare Diseases. 11(1)
بيانات النشر: Springer Nature
مصطلحات موضوعية: Medicine(all), Genetics(clinical), Pharmacology (medical), General Medicine, Genetics (clinical)
اللغة: English
تدمد: 1750-1172
DOI: 10.1186/s13023-016-0463-6
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4079856e69d56bddaf0ae6a5c004e3f5Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....4079856e69d56bddaf0ae6a5c004e3f5
قاعدة البيانات: OpenAIRE
الوصف
تدمد:17501172
DOI:10.1186/s13023-016-0463-6